Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments | GenomeWeb

By Julia Karow

This article was originally published July 28.

Illumina has taken orders for more than 135 MiSeq instruments and has begun shipping the benchtop platform to early-access customers, the company said last week in a call to discuss its second-quarter financial results.

Second-quarter sequencing revenues grew more than 50 percent, largely driven by HiSeq 2000 sales, as the company reduced its backlog of orders for the system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.